在人类子宫内膜癌细胞中,探索由ARID1A突变/淘汰引起的下游分子通路的改变
Baoling Xing1, Xiaoying Zhang2, Xia Gu2
1Department of Pathology, Affiliated Zhoupu Hospital of Shanghai University of Medicine and Health Sciences, Shanghai, 201318, China. 793506861@qq.com.
Journal of cancer research and clinical oncology
|October 31, 2023
概括
ARID1A基因突变促进子宫内膜癌 (EC) 的发展. 在EC细胞中淘汰ARID1A增强了增殖和微卫星的不稳定性,这表明ARID1A是潜在的治疗点.
科学领域:
- 妇科瘤学 妇科瘤学
- 癌症遗传学 癌症遗传学
- 分子生物学分子生物学
背景情况:
- 子宫内膜癌 (EC) 是一种常见的妇科恶性瘤,由遗传改变驱动.
- 富含AT相互作用域1A (ARID1A) 基因突变是子宫内膜癌发生的早期事件.
- 针对这些遗传改变为EC提供了潜在的治疗策略.
研究的目的:
- 为了研究由ARID1A突变引起的下游分子路径改变.
- 探索ARID1A改变对子宫内膜癌的治疗影响.
- 为进一步研究建立一个ARID1A缺乏的子宫内膜癌细胞系.
主要方法:
- 利用CRISPR/Cas9技术编辑人类子宫内膜癌细胞系Ishikawa中的ARID1A基因.
- 成功创建了一个稳定的石川细胞系,在ARID1A中确认了10bp的删除,导致基因淘汰 (KO).
- 分析了细胞增殖,细胞亡,细胞周期,蛋白质表达,微卫星不稳定性和信号通路激活.
主要成果:
- 与野生类型细胞相比,ARID1A KO细胞表现出减少的亡,加速的G0/G1到S相过渡,以及增强的增殖.
- 缺少ARID1A降低了p21,caspase 7和caspase 9蛋白质水平,并导致高微卫星不稳定性 (MSI-H).
- 转录基因和实验分析显示,ARID1A KO细胞中活化酸酸酶3-激酶 (PI3K) /蛋白激酶B (Akt) 信号传递,MLH1和PR表达减少,p-Akt增加.
结论:
- 在子宫内膜癌中,ARID1A缺乏影响关键的细胞过程,包括增殖,亡和DNA修复.
- 这些发现强调ARID1A作为治疗子宫内膜癌治疗的有前途的治疗点.
- 表明组合疗法的潜力,例如与免疫检查点抑制剂,以提高EC治疗疗效.
相关概念视频
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Loss of Tumor Suppressor Gene Functions
4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K
DNA Damage can Stall the Cell Cycle
9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
MicroRNAs
21.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K


